Regeneron Pharmaceuticals logo

Senior Manager Biostatistics, Clinical Trials

Regeneron Pharmaceuticals

Cambridge, MA; Warren, NJ; Tarrytown, NYHybridPosted 1 day ago$153,500.00 - $250,500.00
Full TimeSenior LevelBioinformatics & Data ScienceBiotechnology
Original posting ↗

Summary

At Regeneron, we use science and innovation to develop life-changing medicines for people with serious diseases. We are seeking a Senior Manager Biostatistics, Clinical Trials to join our Global Development team, supporting our thrombosis therapeutic area in a hybrid work mode. In this role, you will provide statistical leadership across clinical development programs while collaborating with cross-functional development teams.

Job description

Discover your role

  • Design and analyze clinical trials with Medical Directors, Clinical Scientists, and cross-functional partners.
  • Develop clinical study protocols, statistical analysis plans, and statistical methodologies.
  • Collaborate with Statistical Programming on tables, figures, and listings for regulatory reporting.
  • Analyze clinical and non-trial data to support program-level decisions.
  • Prepare reports, presentations, and regulatory communications, including agency meeting support.
  • Lead research on innovative statistical methods and clinical trial applications.
  • Mentor statisticians, oversee junior team members, and support contract staff management.
  • You thrive in a collaborative environment and influence scientific decision-making.

This role requires

  • PhD in Statistics/Biostatistics with 4+ years of pharmaceutical industry experience, or MS with 8+ years.
  • Strong knowledge of drug discovery, drug development, and clinical trial strategy.
  • Solid expertise in statistical analysis methodologies, experimental design, and clinical trial design.
  • Proficiency with statistical software such as R or SAS.
  • Ability to assess endpoints, evaluate analytical tools, and apply novel statistical methods.
  • Experience interpreting data and communicating results to project teams, management, and regulatory agencies.
  • Demonstrated leadership, influence, and collaboration skills in cross-functional settings.
  • Strong critical thinking, time management, and communication skills in a fast-paced environment.

Requirements

  • PhD in Statistics/Biostatistics with 4+ years of pharmaceutical industry experience, or MS with 8+ years
  • Strong knowledge of drug discovery, drug development, and clinical trial strategy
  • Solid expertise in statistical analysis methodologies, experimental design, and clinical trial design
  • Proficiency with statistical software such as R or SAS
  • Ability to assess endpoints, evaluate analytical tools, and apply novel statistical methods
  • Experience interpreting data and communicating results to project teams, management, and regulatory agencies
  • Demonstrated leadership, influence, and collaboration skills in cross-functional settings
  • Strong critical thinking, time management, and communication skills in a fast-paced environment

Benefits

  • Annual Bonuses
  • Incentive Plans
  • Equity Awards
  • Pension or Retirement Benefits
  • 401(k) Company Match
  • Health and Wellness Programs
  • Fitness Centers
  • Medical, Dental & Vision
  • Paid Time Off
  • Family Support Benefits

Company overview

Regeneron Pharmaceuticals is a leading American biotechnology company founded in 1988 and headquartered in Tarrytown, New York. The company specializes in inventing, developing, and commercializing life-transforming medicines for people with serious diseases. Regeneron is renowned for its innovative antibody technologies and has developed several groundbreaking therapies, including EYLEA® for retinal diseases, DUPIXENT® for inflammatory conditions, and the COVID-19 antibody cocktail REGEN-COV®. The company operates with a strong focus on research and development across multiple therapeutic areas including ophthalmology, oncology, cardiovascular diseases, and rare genetic disorders. Regeneron's proprietary VelocImmune® technology platform enables the rapid generation of fully human monoclonal antibodies. With over 15,000 employees globally and annual revenues exceeding $14 billion, Regeneron has established itself as a major force in the biotechnology industry, consistently ranking among the top-performing pharmaceutical companies and maintaining a robust pipeline of investigational therapies.

Explore more jobs of your matchFind more biopharma roles with GetBioJob.